Fri.Nov 25, 2022

article thumbnail

AI will continue to attract investment in near future in the healthcare industry

Pharmaceutical Technology

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’. In this survey-based report tracker, digital media was prioritised as a top current investment target, with 53% of surveyed respondents confirming that their companies are currentl

Big Data 363
article thumbnail

Here's how some therapists are tackling structural racism in their practice

NPR Health - Shots

A new wave of counselors is supporting people of color by 'decolonizing' the practice of therapy. They aim to make therapy more culturally responsive and to take generational trauma into account.

129
129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ozempic compensating for Wegovy’s supply shortage due to high demand

Pharmaceutical Technology

In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022. In the meantime, however, Novo Nordisk’s Ozempic, another version of semaglutide indicated particularly for patients with type 2 diabetes, has picked up the slack by being used off-label for obesity patients.

Marketing 279
article thumbnail

Beijing adds new COVID quarantine centers, sparking panic buying

NPR Health - Shots

Residents in the capital have been emptying store shelves in supermarkets and overwhelming delivery apps as Beijing's government steps up construction of COVID quarantine centers.

120
120
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Japan’s MHLW approves Daiichi Sankyo’s breast cancer treatment

Pharmaceutical Technology

Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted approval for Daiichi Sankyo ’s Enhertu (trastuzumab deruxtecan) to treat HER2-positive unresectable or recurrent breast cancer in adults. The treatment is indicated for usage in such patients following previous chemotherapy, comprising trastuzumab and a taxane. The latest development was based on the findings from the international, head-to-head, open-label, randomised Phase III DESTINY-Breast03 trial which analysed the efficacy a

Antibody 263
article thumbnail

Taking the right forecasting approach for rare diseases

pharmaphorum

There are approximately 7,000 different types of rare disease and researchers estimate that there are more than 300 million people worldwide living with such a condition, according to the National Institutes of Health (NIH). However, only 5% of rare diseases are estimated to have at least one approved treatment, known as “orphan” therapies. A rare disease is any disease that affects a small percentage of the population.

Marketing 122

More Trending

article thumbnail

mRNA can deliver universal flu vaccine, say US researchers

pharmaphorum

Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. While the shot is still in preclinical development, if it works in human trials it could raise the prospect of eventually sidestepping the annual scramble to guess the most likely strains to be circulating in the following flu season, and protect against future flu pandemics.

article thumbnail

Who’s hiring who? Hiring activity related to environmental sustainability decreased by 2% in the pharmaceutical industry in Q3 2022

Pharmaceutical Technology

The global pharmaceutical industry experienced a 2% drop in new job postings related to environmental sustainability in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to a 2% increase in the previous quarter and a 22% increase versus Q3 2021. Notably, Building Cleaning Workers jobs accounted for a 9% share of the global pharmaceutical industry’s environmental sustainability-related total new job postings in Q3 2022, up 1% over the

Nurses 100
article thumbnail

A possible vaccine against the bacteria that cause UTIs

Medical Xpress

A team of researchers at Duke University has developed a vaccine against uropathogenic E. coli (UPEC), the type of bacteria that cause urinary tract infections (UTIs) in humans. In their paper published in the journal Science Advances, the group describes how they made their vaccine and its performance when tested in mice and rabbits.

article thumbnail

Who’s hiring who? Hiring activity related to cybersecurity increased by 30% in the pharmaceutical industry in Q3 2022

Pharmaceutical Technology

The global pharmaceutical industry experienced a 30% rise in new job postings related to cybersecurity in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to a 30% increase in the previous quarter and a 70% increase versus Q3 2021. Notably, Registered Nurses jobs accounted for a 9% share of the global pharmaceutical industry’s cybersecurity-related total new job postings in Q3 2022, up 1315% over the prior quarter.

Nurses 100
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Q&A: Siddhartha Mukherjee on the rapid pace of cancer research and ‘luminous’ life of cells

STAT News

The first cells Siddhartha Mukherjee ever saw were T cells, pulled from a mouse spleen and plated onto the microscope slide, given chemicals to coax them to grow. When he looked down the scope, he was struck by the life in them, marveling at what he called their “inner glow and luminous fullness.” That thrill Mukherjee feels each time he sees life under the microscope carries into his new book, “The Song of the Cell.

article thumbnail

Who’s hiring who? Hiring activity related to cloud decreased by 8% in the pharmaceutical industry in Q3 2022

Pharmaceutical Technology

The global pharmaceutical industry experienced an 8% drop in new job postings related to cloud in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to an 8% increase in the previous quarter and a 21% increase versus Q3 2021. Notably, Software and Web Developers, Programmers, and Testers jobs accounted for a 19% share of the global pharmaceutical industry’s cloud -related total new job postings in Q3 2022, down 17% over the prior quart

article thumbnail

Blood group can predict risk of contracting viral disease

Medical Xpress

The risk of being infected by parvovirus is elevated in those people who have blood group Rh(D), according to a study published in The Journal of Infectious Diseases by researchers from Karolinska Institutetin Sweden in collaboration with Octapharma.

article thumbnail

Who’s hiring who? Hiring activity related to artificial intelligence increased by 7% in the pharmaceutical industry in Q3 2022

Pharmaceutical Technology

The global pharmaceutical industry experienced a 7% drop in new job postings related to artificial intelligence in Q3 2022 compared with the previous quarter, according to GlobalData’s Jobs Analytics. This compares to a 7% increase in the previous quarter and a 63% increase versus Q3 2021. Notably, General and Operations Managers jobs accounted for an 11% share of the global pharmaceutical industry’s artificial intelligence-related total new job postings in Q3 2022, up 12% over the p

Scientist 100
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

FDA rejects Spectrum’s lung cancer drug poziotinib

pharmaphorum

The FDA has issued a complete response letter (CRL) to Spectrum Pharma for poziotinib, its pan HER2 inhibitor for a form of lung cancer, according to South Korea’s Hanmi Pharma, which originally developed the drug. Hanmi reported the FDA’s rejection of the marketing application first, as the CRL emerged during the Thanksgiving holiday in the US and the Korean company wanted to eliminate “unnecessary misunderstandings” about the timing of the disclosure given the time diff

Drugs 98
article thumbnail

Investigating plasma to predict COVID-19 progression

Medical Xpress

Just as oil is essential to keep a car's motor running, blood is essential to keep the body functioning. The presence of particular proteins in the plasma, the liquid component of blood, may signal the presence of a disease or indicate the severity of a condition. Now, researchers in Japan have uncovered several key plasma proteins that are related to severe COVID-19.

Protein 98
article thumbnail

Health Innovators – Paolo Borella

pharmaphorum

In our final interview from Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock sits down with Paolo Borella, who runs the new VITA digital health accelerator in Italy. Paolo explains how the accelerator works, what the start-ups get, and how it benefits the various partners involved. Jonah and Paolo also talk a bit about what makes an accelerator work and why industry connections are such an important part of the accelerator equation.

98
article thumbnail

Older adults live longer in counties with greater age bias, researchers find

Medical Xpress

Older adults living in counties with greater age bias had better health outcomes than those living in areas with less age bias, according to University of Massachusetts Amherst researchers, who were surprised at the findings.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

pharmaphorum

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure – black-painted and as yet under construction, gigantic cranes and all – that is the Chiesi Group’s new Biotech Centre of Excellence, you would be forgiven for thinking this was just another laboratory and/or pharmaceutical manufacturing plant; because it quite simply isn’t.

article thumbnail

What is a ketamine therapy session like? A Philly-based therapist explains her process

Medical Xpress

Jess Jones, a licensed clinical social worker, treats a number of patients with ketamine-assisted therapy—where clients take ketamine, prescribed by a psychiatrist, in a series of sessions to treat severe depression or other serious mental health issues.

article thumbnail

World Antimicrobial Resistance (AMR) Awareness Week: Preventing AMR Together

XTalks

This week marked World Antimicrobial Awareness Week, which is a global campaign celebrated every year to help raise awareness and understanding of antimicrobial resistance (AMR). The theme of this year’s World Antimicrobial Awareness Week is “Preventing Antimicrobial Resistance Together,” which highlights the need for collective action in the fight against AMR.

article thumbnail

Young adults with caries can improve their oral health

Medical Xpress

Young adults with extensive caries disease often have a high propensity for risk in terms of oral health. At the same time, with the right support and treatment, they can modify their unhealthy behaviors. A thesis at the University of Gothenburg describes the challenges involved in helping patients in this vulnerable category.

97
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Depressive therapy Spravato demonstrates superior efficacy

Pharma Times

Research supports use of Spravato nasal spray in adults with major depressive disorder

Research 129
article thumbnail

UK nurses strike latest crisis for health service

Medical Xpress

With record waiting times, staff shortages, financial black holes and now a nurses strike over pay, the UK's state-run National Health Service is facing an unprecedented crisis.

Nurses 96
article thumbnail

Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation

Pharma Times

Treatment involves adults with certain forms of advanced stomach and oesophageal cancer

132
132
article thumbnail

EU launches AI-powered real-world data project for cancer therapies

pharmaphorum

The European Commission has provided around €7 million ($7.2 million) in funding to a new project that aims to boost the ability of hospitals within the EU to collect real-world data (RWD) to gauge the effectiveness of novel cancer therapies. Dubbed ONCOVALUE, the initiative will set up a consortium that will develop an artificial intelligence (AI) platform that will be used for routine collection and analysis of clinical data on new oncology medicines to support their assessment by regulators a

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Could these antiviral pills treat long COVID?

Medical Xpress

Could Paxlovid solve one of the pandemic's biggest puzzles? A new study at Stanford University aims to find out.

98
article thumbnail

21 CFR PART 11 - Guidance for Industry

Pharma Tutor

21 CFR PART 11 - Guidance for Industry. admin. Sat, 11/26/2022 - 12:48. This guidance is intended to describe the FDA's current thinking regarding the scope and application of part 11 of Title 21 of the Code of Federal Regulations (CFR); Electronic Records; Electronic Signatures and is in effect since August 20 1997.

article thumbnail

We're told to 'eat a rainbow' of fruit and vegetables: Here's what each color does in our body

Medical Xpress

Nutritionists will tell you to eat a rainbow of fruit and vegetables. This isn't just because it looks nice on the plate. Each color signifies different nutrients our body needs.

75
article thumbnail

New patent for AADI drug FYARRO

Drug Patent Watch

Annual Drug Patent Expirations for FYARRO Fyarro is a drug marketed by Aadi and is included in one NDA. There are four patents protecting this drug. This drug has one…. The post New patent for AADI drug FYARRO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.